Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Onset Type 2 Diabetes”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Post-approval studies (Phase 4)Study completedNCT01107717
What this trial is testing

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM

Who this might be right for
Diabetes
The University of Texas Health Science Center at San Antonio 318
Not applicableActive Not RecruitingNCT02488733
What this trial is testing

Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients

Who this might be right for
Type 2 Diabetes Mellitus
Azienda Ospedaliera Santa Maria, Terni, Italy 30
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Not applicableNot Yet RecruitingNCT07307040
What this trial is testing

Precision Diabetes Management: Integrated East-West Approach

Who this might be right for
Early-Onset Type 2 Diabetes
Peking Union Medical College Hospital 2,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06964087
What this trial is testing

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Who this might be right for
Type I Diabetes
Op-T LLC 72
Testing effectiveness (Phase 2)Looking for participantsNCT05067621
What this trial is testing

Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes MellitusImpaired Glucose ToleranceNon-Alcoholic Fatty Liver Disease+1 more
Yale University 60
Not applicableLooking for participantsNCT07097415
What this trial is testing

The Application of Continuous Blood Glucose Monitoring in Optimizing the Management of Type 2 Diabetes

Who this might be right for
Continuous Glucose MonitoringType 2 Diabetes (T2DM)
Peking University 600
Not applicableStudy completedNCT06913881
What this trial is testing

Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Karolinska Institutet 92,100
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Post-approval studies (Phase 4)Study completedNCT01109927
What this trial is testing

Early Insulin Treatment in Patients With Latent Autoimmune Diabetes

Who this might be right for
Diabetes, AutoimmuneDiabetes Mellitus, Adult-Onset
Lund University Hospital 42
Not applicableEnded earlyNCT02456051
What this trial is testing

Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients

Who this might be right for
Diabetes Mellitus, Adult-OnsetDiabetes ComplicationsCarcinoma, Pancreatic Ductal+1 more
University of Roma La Sapienza 21